A major US trial has found that structured healthy lifestyle programs can slow memory loss in older adults, regardless of ...

A new real-world analysis from UK drugmaker Indivior (Nasdaq: INDV) suggests that patients with opioid use disorder (OUD) ...

Eli Lilly today announced positive top-line results from the Phase III BRUIN CLL-314 clinical trial of Jaypirca ...

Russia is currently experiencing a strong increase in the sales of drugs against alcoholism, as the number of citizens, who ...

Privately-held Italian pharma company Alfasigma has announced positive topline results from the OLINGUITO Phase III trial of ...

US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...

US pharma giant Merck & Co was trading 4% lower in pre-market Tuesday after the group presented its second quarter 2025 ...

Family-owned Boehringer Ingelheim, now Germany’s largest drugmaker by revenue, has reported positive growth in the first half ...

US biotech PTC Therapeutics’ shares trading up 4.8% to $46.48 in after-hours activity yesterday, as it announced that the US ...

AstraZeneca (LSE: AZN) posted a robust second-quarter 2025 performance, lifted by record growth in its US business and solid ...

Sarepta Therapeutics (Nasdaq: SRPT) has been cleared by the American medicines regulator to resume shipments of its gene ...

The US Food & Drug Administration (FDA) has approved Danish biotech Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd; ...